Journal of Lipids / 2013 / Article / Tab 3

Research Article

Association of RXR-Gamma Gene Variants with Familial Combined Hyperlipidemia: Genotype and Haplotype Analysis

Table 3

Haplotype frequencies in all FCHL affected and controls for the five analysed SNPs.

IDHaplotypesCase ( )Control ( ) valueOdds ratio [95% CI]

1CGCGC0.130 (41)0.134 (21)0.8621261.052 [0.594~1.861]
2CGTAG0.070 (22)0.077 (12)0.9136620.960 [0.463~1.994]
3CGTGC0.032 (10)0.058 (9)0.2153090.558 [0.219~1.420]
4CTCGC0.077 (24)0.09 (14)0.7803970.907 [0.456~1.804]
5CTTAC0.038 (12)0.013 (2)0.1193773.081 [0.696~13.636]
6CTTAG0.189 (59)0.115 (18)0.0480312.020 [1.137~3.589]
7CTTGC0.051 (16)0.096 (15)0.1019780.547 [0.263~1.137]
8TGTGC0.054 (17)0.135 (21)0.023610.386 [0.196~0.761]
9TTTGC0.234 (73)0.220 (34)0.4572511.194 [0.748~1.905]

CI: confidence interval; SNPs: single nucleotide polymorphisms; FCHL: familial combined hyperlipidemia.
All frequencies <0.03 have been ignored in analysis. Loci chosen for hap-analysis: rs1128977, rs2651860, rs2134095, rs283696, and rs10918169.
The number of chromosomes valid for analysis is reported in parentheses (312 out of 384 chromosomes for the 192 FCHL affected and 156 out of 238 chromosomes for the 119 controls). Global is 18.905838 while df = 8. Fisher’s value is 0.015506; Pearson’s value is 0.015371.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.